Glucotrack adds Dr. Usman Latif to clinical advisory team for integrated glucose monitoring

Glucotrack, Inc.

Appoints Usman Latif, MD, MBA, a neuromodulation and PDN expert, to its clinical advisory team.
Dr. Latif is Associate Professor at Kansas University Medical Center and board-certified anesthesiologist.
Company aims to integrate glucose sensing into spinal cord stimulator leads for PDN patients.
PDN affects ~1 in 5 Americans with diabetes, over 7 million people.
Long-term preclinical study completed showing feasibility and safety of epidural glucose monitoring.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.